{"title":"一种经过改造的 Cas12i 核酸酶,是动植物基因组编辑的高效工具","authors":"Zhiqiang Duan, Yafeng Liang, Jialei Sun, Hongjin Zheng, Tong Lin, Pengyu Luo, Mengge Wang, Ruiheng Liu, Ying Chen, Shuhua Guo, Nannan Jia, Hongtao Xie, Meili Zhou, Minghui Xia, Kaijun Zhao, Shuhui Wang, Na Liu, Yongling Jia, Wei Si, Qitong Chen, Jian-Kang Zhu","doi":"10.1016/j.xinn.2024.100564","DOIUrl":null,"url":null,"abstract":"<p>The type V-I CRISPR-Cas system is becoming increasingly more attractive for genome editing. However, natural nucleases of this system often exhibit low efficiency, limiting their application. Here, we utilized structure-guided rational design and protein engineering to optimize an uncharacterized Cas12i nuclease, Cas12i3. As a result, we developed Cas-SF01, a Cas12i3 variant that exhibits significantly improved gene-editing activity in mammalian cells. Cas-SF01 shows comparable or superior editing performance compared to SpCas9 and other Cas12 nucleases. Compared to natural Cas12i3, Cas-SF01 has an expanded PAM range and effectively recognizes NTTN and noncanonical NATN and TTVN PAMs. Additionally, we identified an amino acid substitution, D876R, that markedly reduced the off-target effect while maintaining high on-target activity, leading to the development of Cas-SF01<sup>HiFi</sup> (high-fidelity Cas-SF01). Finally, we show that Cas-SF01 has high gene-editing activities in mice and plants. Our results suggest that Cas-SF01 can serve as a robust gene-editing platform with high efficiency and specificity for genome editing applications in various organisms.</p>","PeriodicalId":36121,"journal":{"name":"The Innovation","volume":"50 1","pages":""},"PeriodicalIF":33.2000,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An engineered Cas12i nuclease that is an efficient genome editing tool in animals and plants\",\"authors\":\"Zhiqiang Duan, Yafeng Liang, Jialei Sun, Hongjin Zheng, Tong Lin, Pengyu Luo, Mengge Wang, Ruiheng Liu, Ying Chen, Shuhua Guo, Nannan Jia, Hongtao Xie, Meili Zhou, Minghui Xia, Kaijun Zhao, Shuhui Wang, Na Liu, Yongling Jia, Wei Si, Qitong Chen, Jian-Kang Zhu\",\"doi\":\"10.1016/j.xinn.2024.100564\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The type V-I CRISPR-Cas system is becoming increasingly more attractive for genome editing. However, natural nucleases of this system often exhibit low efficiency, limiting their application. Here, we utilized structure-guided rational design and protein engineering to optimize an uncharacterized Cas12i nuclease, Cas12i3. As a result, we developed Cas-SF01, a Cas12i3 variant that exhibits significantly improved gene-editing activity in mammalian cells. Cas-SF01 shows comparable or superior editing performance compared to SpCas9 and other Cas12 nucleases. Compared to natural Cas12i3, Cas-SF01 has an expanded PAM range and effectively recognizes NTTN and noncanonical NATN and TTVN PAMs. Additionally, we identified an amino acid substitution, D876R, that markedly reduced the off-target effect while maintaining high on-target activity, leading to the development of Cas-SF01<sup>HiFi</sup> (high-fidelity Cas-SF01). Finally, we show that Cas-SF01 has high gene-editing activities in mice and plants. Our results suggest that Cas-SF01 can serve as a robust gene-editing platform with high efficiency and specificity for genome editing applications in various organisms.</p>\",\"PeriodicalId\":36121,\"journal\":{\"name\":\"The Innovation\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":33.2000,\"publicationDate\":\"2024-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Innovation\",\"FirstCategoryId\":\"95\",\"ListUrlMain\":\"https://doi.org/10.1016/j.xinn.2024.100564\",\"RegionNum\":1,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Innovation","FirstCategoryId":"95","ListUrlMain":"https://doi.org/10.1016/j.xinn.2024.100564","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
An engineered Cas12i nuclease that is an efficient genome editing tool in animals and plants
The type V-I CRISPR-Cas system is becoming increasingly more attractive for genome editing. However, natural nucleases of this system often exhibit low efficiency, limiting their application. Here, we utilized structure-guided rational design and protein engineering to optimize an uncharacterized Cas12i nuclease, Cas12i3. As a result, we developed Cas-SF01, a Cas12i3 variant that exhibits significantly improved gene-editing activity in mammalian cells. Cas-SF01 shows comparable or superior editing performance compared to SpCas9 and other Cas12 nucleases. Compared to natural Cas12i3, Cas-SF01 has an expanded PAM range and effectively recognizes NTTN and noncanonical NATN and TTVN PAMs. Additionally, we identified an amino acid substitution, D876R, that markedly reduced the off-target effect while maintaining high on-target activity, leading to the development of Cas-SF01HiFi (high-fidelity Cas-SF01). Finally, we show that Cas-SF01 has high gene-editing activities in mice and plants. Our results suggest that Cas-SF01 can serve as a robust gene-editing platform with high efficiency and specificity for genome editing applications in various organisms.
期刊介绍:
The Innovation is an interdisciplinary journal that aims to promote scientific application. It publishes cutting-edge research and high-quality reviews in various scientific disciplines, including physics, chemistry, materials, nanotechnology, biology, translational medicine, geoscience, and engineering. The journal adheres to the peer review and publishing standards of Cell Press journals.
The Innovation is committed to serving scientists and the public. It aims to publish significant advances promptly and provides a transparent exchange platform. The journal also strives to efficiently promote the translation from scientific discovery to technological achievements and rapidly disseminate scientific findings worldwide.
Indexed in the following databases, The Innovation has visibility in Scopus, Directory of Open Access Journals (DOAJ), Web of Science, Emerging Sources Citation Index (ESCI), PubMed Central, Compendex (previously Ei index), INSPEC, and CABI A&I.